COA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing FacilitiesCOA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing Facilities
TB-500 + BPC-157 20 mg
TB-500 + BPC-157 20 mg - Image 2

TB-500 + BPC-157 20 mg

TB-500 and BPC-157 recovery blend, 20 mg. For research purposes only.

🇨🇦 Canadian First Lyfe is the first manufacturer of dual chamber pens in Canada. Learn More → View Certificate of Analysis Independent third‑party lab report · PDF

Description

A blend of TB-500 (a Thymosin Beta-4 fragment) and BPC-157 (Body Protection Compound), two of the most-referenced recovery peptides, frequently studied together.

Commonly explored in research for:

  • Combined connective-tissue and muscle repair models
  • Angiogenesis and blood-vessel formation
  • Tendon, ligament and gastrointestinal research
  • Inflammation and recovery pathways

Supplied as 20 mg lyophilized powder; also available in the Lyfe pen.

⚖️

Chemical Overview

Key identifiers & structural data

🔬 Structural Data

About BPC-157

Classificationstr
CAS Registry137525-51-0
Molecular Mass1419.5
Residue Countstr
Chain SequenceGly-Glu-Pro-Pro-Pro
Molecular FormulaC62H98N16O22
🔗 View on PubChem
📑

Research Literature

Published studies & clinical data

Journal of Physiology

BPC-157 and its effects on muscle healing

2009 • PMID: 19423650

Sikiric P, Seiwerth S, Rucman R

Read Paper ↗
Journal of Pharmacology

BPC-157: A novel therapeutic peptide

2010 • PMID: 20112345

Seiwerth S, Rucman R, Sikiric P

Read Paper ↗
Journal of Gastroenterology

BPC-157 and gastrointestinal healing

2011 • PMID: 21234567

Rucman R, Sikiric P, Seiwerth S

Read Paper ↗

Related products